Jonathan Bye
Lawyers
Associate in our Corporate practice, based in Northern California.
Experience highlights
Recent Representations
- RAPT Therapeutics $150 million at-the-market offering
- Recursion Pharmaceuticals $300 million at-the-market offering
- IDEAYA Biosciences $250 million at-the-market offering
- IDEAYA Biosciences $201 million equity offering
- AN2 Therapeutics $100 million at-the-market offering
- Pacific Biosciences $201.25 million follow-on offering
- TTX $300 million medium-term note offering
- Recursion Pharmaceuticals $150 million private placement
- IDEAYA Biosciences $92 million follow-on offering
- Carvana $3.275 billion senior notes offering
- Carvana $1.25 billion follow-on offering
- AN2 Therapeutics $69 million IPO
- Nurix Therapeutics $150 million at-the-market offering
- IDEAYA Biosciences $92 million follow-on offering
- RAPT Therapeutics $143.7 million follow-on offering
- Nurix Therapeutics $160.4 million follow-on offering
Education
J.D., University of Michigan Law School
- cum laude
B.A., Philosophy, UC Berkeley
Professional history
- Davis Polk since 2018
Qualifications and admissions
- State of California